FOLH1 and posterior cortical atrophy: To date, the most widely used cell lines in preclinical PCa studies are GRPR-positive PC-3 (doubling time ~33 h) and PSMA-positive LNCaP (doubling time ~60 h) cells, exhibiting varying growth rates, as well as DU145 (doubling time ~34 h) [31,32].